Performance of Two HCV RNA Assays during Protease Inhibitor-Based Triple Therapy in Patients with Advanced Liver Fibrosis and Cirrhosis

INTRODUCTION: On-treatment HCV RNA measurements are crucial for the prediction of a sustained virological response (SVR) and to determine treatment futility during protease inhibitor-based triple therapies. In patients with advanced liver disease an accurate risk/benefit calculation based on reliabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Maasoumy, Benjamin, Hunyady, Bela, Calvaruso, Vincenza, Makara, Mihály, Vermehren, Johannes, Haragh, Attila, Susser, Simone, Bremer, Birgit, Cloherty, Gavin, Manns, Michael P., Craxì, Antonio, Wedemeyer, Heiner, Sarrazin, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229112/
https://www.ncbi.nlm.nih.gov/pubmed/25389779
http://dx.doi.org/10.1371/journal.pone.0110857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229112/
https://www.ncbi.nlm.nih.gov/pubmed/25389779
http://dx.doi.org/10.1371/journal.pone.0110857

Ejemplares similares